SynthesisMicrobiologyOpen2026
Gut Microbiota Alterations Associated With Colonization by Multidrug-Resistant Organisms in ICU Patients: First Systematic Review and Meta-Analysis.
Synthesis in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07719673 (Enteral Nutrition to Enhance Colonization Resistance Through Gut Microbiota Modulation in Critically Ill Patients), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Enteral Nutrition to Enhance Colonization Resistance Through Gut Microbiota Modulation in Critically Ill Patients: A Randomized Controlled Pilot Trial
Who cites it
1 citing paper in PubMed.
- The gut reservoir of carbapenem-resistant Enterobacterales: from dysbiosis and colonization to infection and decolonization, with a focus on patients with hematologic malignancies - a narrative review.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colonization by multidrug-resistant organisms (MDROs) is a risk factor for infection and mortality in critically ill patients, yet current strategies to prevent or control dissemination show variable effectiveness. Whether alterations in microbiota structure and composition (dysbiosis) are associated with MDRO colonization in critically ill patients is an open question this study aims to address. We conducted the first systematic review and meta-analysis comparing intestinal microbiota structure (diversity) and composition (relative abundance of bacteria) between colonized critically ill patients and noncolonized/control patients. PubMed, Web of Science, and Scopus were systematically searched from inception to September 2025. The study protocol was preregistered on Open Science Framework, under embargo. Of 3003 records identified, 11 studies (n = 2823 patients) published between 2019 and 2025 met the inclusion criteria. The most frequently reported colonizing strains in MDROs-colonized patients were vancomycin-resistant Enterococci (58.2%), carbapenem-resistant Enterobacterales (21.6%), extended-spectrum β-lactamase-producing Enterobacterales (13.4%). All studies employed 16S ribosomal RNA sequencing to assess intestinal microbiota. Colonized critically ill patients had lower values of dominance/evenness and richness, reaching significantly lower values of information when compared with controls (mean difference in Shannon index = -1.18; 95% CI, -1.84 to -0.52; p < 0.001). Composition investigation revealed a significant increase in the Pseudomonadota phylum and the Enterobacteriaceae family in MDROs-colonized patients. Current evidence is limited and largely associational. Nevertheless, altered intestinal microbiota consistently characterize colonized critically ill patients. Further studies are warranted to determine whether early detection of dysbiosis can enhance early prediction/diagnosis of MDROs-colonization and guide the targeted microbiota-based strategies to prevent infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.